5 insiders reported 34 Form 4 transactions for Terns Pharmaceuticals, Inc. (TERN) over the past 18 months (most recent 2026-04-02). Recent activity: Kuriakose Emil (Chief Medical Officer) Sell 942 shares, Burroughs Amy L. (Chief Executive Officer) Buy 14,583 shares, Burroughs Amy L. (Chief Executive Officer) Sell 11,813 shares, Burroughs Amy L. (Chief Executive Officer) Sell 2,770 shares, Burroughs Amy L. (Chief Executive Officer) Buy 14,583 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Kuriakose Emil | Chief Medical Officer | Sell | 942 | $49,693 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 11,813 | $550,131 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,770 | $131,021 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,341 | $89,122 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 8,159 | $319,996 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 4,083 | $162,503 |
| 2026-01-16 | Gengos Andrew | Chief Financial Officer | Buy | 68,750 | $0 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 61,228 | $2.3M |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 7,521 | $282,263 |
| 2026-01-16 | Kuriakose Emil | Chief Medical Officer | Buy | 56,250 | $0 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 21,551 | $99,997 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Sell | 71,339 | $2.7M |
| 2026-01-06 | Kuriakose Emil | Chief Medical Officer | Sell | 200 | $7,920 |
| 2026-01-06 | Kuriakose Emil | Chief Medical Officer | Sell | 955 | $36,634 |
| 2025-11-05 | Quigley Jill M. | Director | Buy | 24,520 | $226,565 |
| 2025-11-05 | Quigley Jill M. | Director | Sell | 24,520 | $441,360 |
| 2025-10-02 | Kuriakose Emil | Chief Medical Officer | Sell | 944 | $7,410 |
| 2025-07-03 | Kuriakose Emil | Chief Medical Officer | Sell | 853 | $3,642 |
Source: SEC Form 4 filings · as of 2026-04-02